2
Views
8
CrossRef citations to date
0
Altmetric
Original articles

The Influence of Somatostatin on Postoperative Outcome after Elective Pancreatic Surgery

, , &
Pages 62-65 | Received 27 Feb 1997, Accepted 06 Sep 1997, Published online: 16 Nov 2020

References

  • Fernandezdel Castuto C., Rattner D. W., Warshaw A. L. Standards for panereatie resection in the 1990s. Arch Surg 1993; 130: 295-300.
  • Pitt H. A. Curative treatment for pancreatic neoplasms. Surg Clin North Am 1995, 75: 891-904.
  • Yeo C. J. Management of complications following pancreaticoduodenectomy. Surg Clin North Am 1995; 75: 913-924.
  • St. Laurent M., Frazee R. C. Radical pancreatic resection for benign and malignant disease. Am Surg 1993; 59: 69-73.
  • Edge S. B., Schmieg R. E., Rosenlof L. K., Welheim M. C. Pancreas cancer resection outcome in American University Centers in 1989–1990. Cancer 1993; 71: 3502-3507.
  • Marcus S. G., Cohen H., Ranson J. H. C. Optimal management of the pancratic remnant after pancreaticoduodenectomy. Ann Surg 1995; 221: 635-648.
  • Guillemin R. Somatostatin: The early days. Digestion 1993; 54 (suppl. I): 3-6.
  • Heintges T., Lüthen R., Niederau C. Inhibition of exocrine pancreatic secretion by somatostatin and its analogues. Digestion 1994; 55 (suppl. 1): 1-9.
  • Klempa I., Baca I., Menzel J., Sehuszdiarra V. Auswirkung von Somatostatin auf die basale und stimulierte exokrine Pankreassekretion nach partieller Duodenopankreatektomie. Chirurg 1991; 62: 293-299.
  • Pezzilli R., Gulio L., di Stefano M., Ventrucci M., Ancona D. Treatment of pancreatic ascites with somatostatin. Pancreas 1993; 8: 120-122.
  • Ysebaert D., Van Hee R., Hubens G., Vaneerdeweg W., Eyskens E. Management of digestive fistulas. Scan J Gastroenterol 1994: 29 (suppl. 207): 42-44.
  • Ysebaert D., Van Hee R., Hubens G., Vaneerdeweg W., Schoofs E. Treatment of postoperative pancreatic and enterocutaneous fistulas with total parenteral nutrition and somatostatin. Hr Surg 1992; 79: S118.
  • Torres A. J., Landa J. I., Moreno-Azcoita M., Arguello J. M., Silecchia G., Castro J., Hernandez-Merlo F., Jover J. M., Moreno-Gonzales E., Balibrea J. L. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992; 127: 97-100.
  • Malfertheiner P., Mayer D., Büchler M., Dominguez-Munoz J. E., Schiefer B., Ditschuneit H. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995: 36: 450-455.
  • Mulvihill S., Pappas T. N., Passaro E., Debas H. T. The use of somatostatin and its analogs in the treatment of surgical disorders. Surgery 1986: 100: 467-475.
  • Harris A. G. Somatostatin and somatostatin analogues; pharmacokinetics and pharmacodynamic effects. Gut 1994; 35 (suppl. 3): S1-S4.
  • Meier R. Octreotid — ein Somatostatineanalogon in der Praxis. Praxis 1995; 84: 325-327.
  • Meyer J., Preusser P., Bünte H. Die Bedeutung des Somatostatins für die Senkung der periund postoperativen Komplikationen bei der Whipple-Operation. Zentrallbl Chir 1991; 116: 917-920.
  • Montorsi M., Zago M., Mosca F., Capussotti L., Zotti E., Ribotta G., Fegiz G., Fissi S., Roviaro G., Peracchia A. et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resection: A prospective, controlled, randomized clinical trial. Surgery 1995; 117: 26-31.
  • Büchler M., Friess H., Klempa I., Hermanek P., Sulkowski U., Becker H., Schafmayer A., Baca I., Lorenz B., Meister R. et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992; 163: 125-131.
  • Bassi C., Falconi M., Pederzoli P. Prophylaxis of complications after pancreatic surgery: results of a multicenter trial in Italy. Digestion 1994; 55 (suppl. 1): 41-47.
  • Fleming W. R., Williamson R. C. N. Role of total pancreatectomy in the treatment of patients with end-stage chronic pancreatitis. Br Surg 1995; 82: 1409-1412.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.